FRAX Score Improves Secondary Fracture Prevention

August 23, 2020

New analysis suggests use of FRAX score could improve the secondary prevention of fractures in patients with osteoporosis.

Hormone Therapy Decreases Fracture Risk in Postmenopausal Women

August 21, 2020

Data from the Women's Health Initiative Hormone Therapy trials presented at WCO-IOF-ESCEO 2020 details the reduced risk of fracture seen with hormone therapy in postmenopausal women.

Anorexia During Adolescence Linked to Stunted Growth in Females

August 20, 2020

An analysis of female adolescents admitted for anorexia nervosa found the condition could be linked to stunted growth.

Increased High-Intensity Activity Early in Life Could Decrease Osteoporosis Risk

August 18, 2020

An analysis of physical activity from ages of 12-16 with bone mineral density at 25 years of age sheds light on the impact of increased high-intensity physical activity.

Combination Therapy with SGLT2s and Metformin Does Not Increase Fracture Risk

August 15, 2020

An analysis of 25 trials indicates SGLT2s and metformin did not increase fracture risk and did not negatively impact bone mineral density among type 2 diabetics.

Three-Year Bone Density Follow-ups Do Not Increase Risk Prediction Accuracy

July 30, 2020

New data suggests bone density measurement follow-ups within 3 years of baseline assessment are unnecessary and a potential misuse of resources.

NSAID Use Does Not Hinder Fracture Healing Ability, Study Finds

July 25, 2020

New data is debunking the idea use of NSAIDs slow bone fracture healing in children.

Novel Genetic Score Could Reduce Unneccessary Fracture Risk Screenings

July 22, 2020

A novel polygenic risk score could help identify patients at a low-risk of fracture from osteoporosis or fragility without need for additional screenings.

Cardiac CT Exams Effective For Assessing Osteoporosis

July 14, 2020

This article originally appeared on DiagnosticImaging.com

New Analysis Strengthens Cardiovascular Safety Profile of Abaloparatide

July 14, 2020

A new analysis is strengthening the safety profile of abaloparatide (Tymlos) in postmenopausal women to prevent risk of fracture.